drug · small molecule
dapagliflozin propanediol
Marketedupdated 3mo agoby $AZN ASTRAZENECA PLC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for heart failure and type 2 diabetes mellitus and 4 investigational indications.
indications
investigational
Type 2 Diabetes
targets
Sodium/glucose cotransporter 2
all catalysts(0)
nothing on the calendar yet
Trials studying dapagliflozin propanediol
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 8, 2026
79 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (54)
- Oct 1, 2041patentUS 12213988*PED
- Oct 1, 2041patentUS 12409186*PED
- Apr 1, 2041method-of-use (U-4140)US 12213988
- Apr 1, 2041method-of-use (U-4140)US 12409186
- Sep 9, 2040patentUS 10973836*PED
- Sep 9, 2040patentUS 11903955*PED
- Mar 9, 2040method-of-use (U-3127)US 10973836
- Mar 9, 2040method-of-use (U-3825)US 11903955
- Jan 18, 2040patentUS 11826376*PED
- Jan 18, 2040patentUS 12472194*PED
- Jul 18, 2039method-of-use (U-3766)US 11826376
- Jul 18, 2039method-of-use (U-4346)US 12472194
- Nov 26, 2030patentUS 8685934*PED4.3y
- Nov 26, 2030patentUS 8685934*PED4.3y
- Jul 18, 2030patentUS 8721615*PED3.9y
- Jul 18, 2030patentUS 8721615*PED3.9y
- Jun 16, 2030patentUS 7919598*PED3.8y
- Jun 16, 2030patentUS 7919598*PED3.8y
- May 26, 2030method-of-use (U-1522)US 86859343.8y
- May 26, 2030method-of-use (U-1522)US 86859343.8y
- Dec 16, 2029compositionUS 79195983.3y
- Dec 16, 2029compositionUS 79195983.3y
- Feb 19, 2029patentUS 7851502*PED2.5y
- Feb 19, 2029patentUS 7851502*PED2.5y
- Sep 21, 2028patentUS 8221786*PED2.1y
- Sep 21, 2028patentUS 8221786*PED2.1y
- Sep 21, 2028patentUS 8361972*PED2.1y
- Sep 21, 2028patentUS 8361972*PED2.1y
- Sep 21, 2028patentUS 8716251*PED2.1y
- Sep 21, 2028patentUS 8716251*PED2.1y
- Aug 19, 2028formulationUS 78515022.0y
- Aug 19, 2028formulationUS 78515022.0y
- Mar 21, 2028formulationUS 82217861.6y
- Mar 21, 2028formulationUS 82217861.6y
- Mar 21, 2028method-of-use (U-493)US 83619721.6y
- Mar 21, 2028method-of-use (U-493)US 83619721.6y
- Mar 21, 2028formulationUS 87162511.6y
- Mar 21, 2028formulationUS 87162511.6y
- Dec 20, 2027patentUS 8501698*PED1.3y
- Dec 20, 2027patentUS 8501698*PED1.3y
- Jun 20, 2027formulationUS 8501698303d
- Jun 20, 2027formulationUS 8501698303d
- Feb 18, 2027patentUS 8329648*PED181d
- Feb 18, 2027patentUS 8329648*PED181d
- Feb 18, 2027patentUS 8906851*PED181d
- Feb 18, 2027patentUS 8906851*PED181d
- Aug 18, 2026method-of-use (U-2213)US 8329648
- Aug 18, 2026method-of-use (U-2212)US 8329648
- Aug 18, 2026method-of-use (U-2139)US 8906851
- Aug 18, 2026method-of-use (U-2139)US 8906851
- Apr 4, 2026patentUS 6515117*PED
- Apr 4, 2026patentUS 6515117*PED
- Oct 4, 2025compositionUS 6515117
- Oct 4, 2025compositionUS 6515117
FDA exclusivities (8)
- Dec 12, 2027PEDPediatric (6mo bonus)1.3y
- Dec 12, 2027PEDPediatric (6mo bonus)1.3y
- Jun 12, 2027NPPNew Product (3y)295d
- Jun 12, 2027NPPNew Product (3y)295d
- Nov 8, 2026PEDPediatric (6mo bonus)79d
- Nov 8, 2026PEDPediatric (6mo bonus)79d
- May 8, 2026M-298Method (3y)
- May 8, 2026M-298Method (3y)
News(3)
- After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenGrowing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.stat · 23d ago
- AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failureAstraZeneca remains "very much on track" to hit its 2030 goal of reaching $80 billion in revenue despite the recent late-stage failure of Wainua in ATTR-cardiomyopathy, CEO Pascal Soriot said durin…biospace · 24d ago
- Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readoutsWith a Phase 3 failure denting the rare disease drug’s prospects, AstraZeneca has little room for error as it plots a path toward its ambitious 2030 sales target.biospace · 29d ago
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that